Circulating microRNAs in Alzheimer's disease: The search for novel biomarkers

Frontiers in Molecular Neuroscience

Volumn 6, Issue AUG, 2013, Pages

  Dorval, Véronique ^a,b   Nelson, Peter T ^c   Hébert, Sébastien S ^a,b  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

^c UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Alzheimer's disease; Biomarker; Diagnosis; microRNA; Mild cognitive impairment

Indexed keywords

AMYLOID PROTEIN; MICRORNA; TAU PROTEIN; UNTRANSLATED RNA;

ALZHEIMER DISEASE; ARTICLE; BLOOD LEVEL; CEREBROSPINAL FLUID LEVEL; DEMENTIA; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DISEASE MARKER; FRONTOTEMPORAL DEMENTIA; HUMAN; INTERMETHOD COMPARISON; MILD COGNITIVE IMPAIRMENT; NERVE DEGENERATION; RNA ANALYSIS; SENSITIVITY AND SPECIFICITY;

EID: 84885070998     PISSN: 16625099     EISSN: None     Source Type: Journal    
DOI: 10.3389/fnmol.2013.00024     Document Type: Article

References (54)

1. Abe, M., and Bonini, N. M. (2013). MicroRNAs and neurodegeneration: role and impact. Trends Cell Biol. 23, 30-36. doi: 10.1016/j.tcb.2012.08.013
2. Alexandrov, P. N., Dua, P., Hill, J. M., Bhattacharjee, S., Zhao, Y., and Lukiw, W. J. (2012). microRNA (miRNA) speciation in Alzheimer's disease (AD) cerebrospinal fluid (CSF) and extracellular fluid (ECF). Int. J. Biochem. Mol. Biol. 3, 365-373.
3. Bekris, L. M., Lutz, F., Montine, T. J., Yu, C. E., Tsuang, D., Peskind, E. R., et al. (2013). MicroRNA in Alzheimer's disease: an exploratory study in brain, cerebrospinal fluid and plasma. Biomarkers 18, 455-466. doi: 10.3109/1354750X.2013.814073
4. Bu, P., Chen, K. Y., Chen, J. H., Wang, L., Walters, J., Shin, Y. J., et al. (2013). A microRNA miR-34a-regulated bimodal switch targets notch in colon cancer stem cells. Cell Stem Cell 12, 602-615. doi: 10.1016/j.stem.2013.03.002
5. Chang, T. C., Yu, D., Lee, Y. S., Wentzel, E. A., Arking, D. E., West, K. M., et al. (2008). Widespread microRNA repression by Myc contributes to tumorigenesis. Nat. Genet. 40, 43-50. doi: 10.1038/ng.2007.30
6. Chintamaneni, M., and Bhaskar, M. (2012). Biomarkers in Alzheimer's disease: a review. ISRN Pharmacol. 2012, 984786. doi: 10.5402/2012/984786
7. Cogswell, J. P., Ward, J., Taylor, I. A., Waters, M., Shi, Y., Cannon, B., et al. (2008). Identification of miRNA changes in Alzheimer's disease brain and CSF yields putative biomarkers and insights into disease pathways. J. Alzheimers Dis. 14, 27-41.
8. Cole, K. A., Attiyeh, E. F., Mosse, Y. P., Laquaglia, M. J., Diskin, S. J., Brodeur, G. M., et al. (2008). A functional screen identifies miR-34a as a candidate neuroblastoma tumor suppressor gene. Mol. Cancer Res. 6, 735-742. doi: 10.1158/1541-7786.MCR-07-2102
9. Delay, C., Mandemakers, W., and Hebert, S. S. (2012). MicroRNAs in Alzheimer's disease. Neurobiol. Dis. 46, 285-290. doi: 10.1016/j.nbd.2012.01.003
10. Dorval, V., Smith, P. Y., Delay, C., Calvo, E., Planel, E., Zommer, N., et al. (2012). Gene network and pathway analysis of mice with conditional ablation of dicer in post-mitotic neurons. PLoS ONE 7:e44060. doi: 10.1371/journal.pone.0044060
11. Geekiyanage, H., and Chan, C. (2011). MicroRNA-137/181c regulates serine palmitoyltransferase and in turn amyloid beta, novel targets in sporadic Alzheimer's disease. J. Neurosci. 31, 14820-14830. doi: 10.1523/JNEUROSCI.3883-11.2011
12. Geekiyanage, H., Jicha, G. A., Nelson, P. T., and Chan, C. (2012). Blood serum miRNA: non-invasive biomarkers for Alzheimer's disease. Exp. Neurol. 235, 491-496. doi: 10.1016/j.expneurol.2011.11.026
13. Gomez-Isla, T., Price, J. L., Mckeel, D. W., Jr., Morris, J. C., Growdon, J. H., and Hyman, B. T. (1996). Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease. J. Neurosci. 16, 4491-4500.
14. Gomperts, S. N., Rentz, D. M., Moran, E., Becker, J. A., Locascio, J. J., Klunk, W. E., et al. (2008). Imaging amyloid deposition in Lewy body diseases. Neurology 71, 903-910. doi: 10.1212/01.wnl.0000326146.60732.d6
15. He, L., He, X., Lim, L. P., De Stanchina, E., Xuan, Z., Liang, Y., et al. (2007). A microRNA component of the p53 tumour suppressor network. Nature 447, 1130-1134. doi: 10.1038/nature05939
16. Hebert, S. S., Papadopoulou, A. S., Smith, P., Galas, M. C., Planel, E., Silahtaroglu, A. N., et al. (2010). Genetic ablation of Dicer in adult forebrain neurons results in abnormal tau hyperphosphorylation and neurodegeneration. Hum. Mol. Genet. 19, 3959-3969. doi: 10.1093/hmg/ddq311
17. Hebert, S. S., Wang, W. X., Zhu, Q., and Nelson, P. T. (2013). A study of small RNAs from cerebral neocortex of pathology-verified Alzheimer's disease, dementia with Lewy bodies, hippocampal sclerosis, frontotemporal lobar dementia, and non-demented human controls. J. Alzheimers Dis. 35, 335-348. doi: 10.3233/JAD-122350
18. Heicklen-Klein, A., and Ginzburg, I. (2000). Tau promoter confers neuronal specificity and binds Sp1 and AP-2. J. Neurochem. 75, 1408-1418. doi: 10.1046/j.1471-4159.2000.0751408.x
19. Holtzman, D. M. (2011). CSF biomarkers for Alzheimer's disease: current utility and potential future use. Neurobiol. Aging 32(Suppl.1), S4-S9. doi: 10.1016/j.neurobiolaging.2011.09.003
20. Hu, G., Drescher, K. M., and Chen, X. M. (2012). Exosomal miRNAs: biological properties and therapeutic potential. Front. Genet. 3:56. doi: 10.3389/fgene.2012.00056
21. Hyman, B. T., Phelps, C. H., Beach, T. G., Bigio, E. H., Cairns, N. J., Carrillo, M. C., et al. (2012). National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease. Alzheimers Dement. 8, 1-13. doi: 10.1016/j.jalz.2011.10.007
22. Ingelson, M., Blomberg, M., Benedikz, E., Wahlund, L. O., Karlsson, E., Vanmechelen, E., et al. (1999). Tau immunoreactivity detected in human plasma, but no obvious increase in dementia. Dement. Geriatr. Cogn. Disord. 10, 442-445. doi: 10.1159/000017187
23. Jicha, G. A., Parisi, J. E., Dickson, D. W., Johnson, K., Cha, R., Ivnik, R. J., et al. (2006). Neuropathologic outcome of mild cognitive impairment following progression to clinical dementia. Arch. Neurol. 63, 674-681. doi: 10.1001/archneur.63.5.674
24. Johnson, S. M., Grosshans, H., Shingara, J., Byrom, M., Jarvis, R., Cheng, A., et al. (2005). RAS is regulated by the let-7 microRNA family. Cell 120, 635-647. doi: 10.1016/j.cell.2005.01.014
25. Kang, J., Lemaire, H. G., Unterbeck, A., Salbaum, J. M., Masters, C. L., Grzeschik, K. H., et al. (1987). The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature 325, 733-736. doi: 10.1038/325733a0
26. Kosaka, N., Iguchi, H., Yoshioka, Y., Takeshita, F., Matsuki, Y., and Ochiya, T. (2010). Secretory mechanisms and intercellular transfer of microRNAs in living cells. J. Biol. Chem. 285, 17442-17452. doi: 10.1074/jbc.M110.107821
27. Kosik, K. S., Rapp, P. R., Raz, N., Small, S. A., Sweatt, J. D., and Tsai, L. H. (2012). Mechanisms of age-related cognitive change and targets for intervention: epigenetics. J. Gerontol. A Biol. Sci. Med. Sci. 67, 741-746. doi: 10.1093/gerona/gls110
28. La Fauci, G., Lahiri, D. K., Salton, S. R., and Robakis, N. K. (1989). Characterization of the 5'-end region and the first two exons of the beta-protein precursor gene. Biochem. Biophys. Res. Commun. 159, 297-304. doi: 10.1016/0006-291X(89)92437-6
29. Landgraf, P., Rusu, M., Sheridan, R., Sewer, A., Iovino, N., Aravin, A., et al. (2007). A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 129, 1401-1414. doi: 10.1016/j.cell.2007.04.040
30. Lehmann, S. M., Kruger, C., Park, B., Derkow, K., Rosenberger, K., Baumgart, J., et al. (2012). An unconventional role for miRNA: let-7 activates Toll-like receptor 7 and causes neurodegeneration. Nat. Neurosci. 15, 827-835. doi: 10.1038/nn.3113
31. Leidinger, P., Backes, C., Deutscher, S., Schmitt, K., Muller, S. C., Frese, K., et al. (2013). A blood based 12-miRNA signature of Alzheimer disease patients. Genome Biol. 14, R78. doi: 10.1186/gb-2013-14-7-r78 [Epub ahead of print].
32. Lin, D. H., Yue, P., Pan, C., Sun, P., and Wang, W. H. (2011). MicroRNA 802 stimulates ROMK channels by suppressing caveolin-1. J. Am. Soc. Nephrol. 22, 1087-1098. doi: 10.1681/ASN.2010090927
33. Lindsay, M. A. (2008). MicroRNAs and the immune response. Trends Immunol. 29, 343-351. doi: 10.1016/j.it.2008.04.004
34. Liu, W., Liu, C., Zhu, J., Shu, P., Yin, B., Gong, Y., et al. (2012). MicroRNA-16 targets amyloid precursor protein to potentially modulate Alzheimer's-associated pathogenesis in SAMP8 mice. Neurobiol. Aging 33, 522-534. doi: 10.1016/j.neurobiolaging.2010.04.034
35. Maes, O. C., Chertkow, H. M., Wang, E., and Schipper, H. M. (2009). MicroRNA: implications for Alzheimer disease and other human CNS disorders. Curr. Genomics 10, 154-168. doi: 10.2174/138920209788185252
36. Mraz, M., Malinova, K., Mayer, J., and Pospisilova, S. (2009). MicroRNA isolation and stability in stored RNA samples. Biochem. Biophys. Res. Commun. 390, 1-4. doi: 10.1016/j.bbrc.2009.09.061
37. Nelson, P. T., Alafuzoff, I., Bigio, E. H., Bouras, C., Braak, H., Cairns, N. J., et al. (2012). Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature. J. Neuropathol. Exp. Neurol. 71, 362-381. doi: 10.1097/NEN.0b013e31825018f7
38. Nelson, P. T., Braak, H., and Markesbery, W. R. (2009). Neuropathology and cognitive impairment in Alzheimer disease: a complex but coherent relationship. J. Neuropathol. Exp. Neurol. 68, 1-14. doi: 10.1097/NEN.0b013e3181919a48
39. Ouyang, Y. B., Lu, Y., Yue, S., and Giffard, R. G. (2012). miR-181 targets multiple Bcl-2 family members and influences apoptosis and mitochondrial function in astrocytes. Mitochondrion 12, 213-219. doi: 10.1016/j.mito.2011.09.001
40. Pasquinelli, A. E., Hunter, S., and Bracht, J. (2005). MicroRNAs: a developing story. Curr. Opin. Genet. Dev. 15, 200-205. doi: 10.1016/j.gde.2005.01.002
41. Portet, F., Ousset, P. J., Visser, P. J., Frisoni, G. B., Nobili, F., Scheltens, P., et al. (2006). Mild Cognitive Impairment (MCI) in medical practice: a critical review of the concept and new diagnostic procedure. Report of the MCI Working Group of the European Consortium on Alzheimer's Disease. J. Neurol. Neurosurg. Psychiatry 77, 714-718. doi: 10.1136/jnnp.2005.085332
42. Sayed, D., and Abdellatif, M. (2011). MicroRNAs in development and disease. Physiol. Rev. 91, 827-887. doi: 10.1152/physrev.00006.2010
43. Schipper, H. M. (2007). Biomarker potential of heme oxygenase-1 in Alzheimer's disease and mild cognitive impairment. Biomark. Med. 1, 375-385. doi: 10.2217/17520363.1.3.375
44. Sheinerman, K. S., Tsivinsky, V. G., Crawford, F., Mullan, M. J., Abdullah, L., and Umansky, S. R. (2012). Plasma microRNA biomarkers for detection of mild cognitive impairment. Aging (Albany NY) 4, 590-605.
45. Tarawneh, R., and Holtzman, D. M. (2010). Biomarkers in translational research of Alzheimer's disease. Neuropharmacology 59, 310-322. doi: 10.1016/j.neuropharm.2010.04.006
46. Thounaojam, M. C., Kaushik, D. K., and Basu, A. (2013). MicroRNAs in the brain: it's regulatory role in neuroinflammation. Mol. Neurobiol. 47, 1034-1044. doi: 10.1007/s12035-013-8400-3
47. Treiber, T., Treiber, N., and Meister, G. (2012). Regulation of microRNA biogenesis and function. Thromb. Haemost. 107, 605-610. doi: 10.1160/TH11-12-0836
48. van Harten, A., Mulders, J., Çevik, C., Kester, M., Scheltens, P., Flier, W. V. D., et al. (2011). "MicroRNA analysis in the spinal fluid of Alzheimer patients: a methodological feasibility study, " in Circulating Nucleic Acids in Plasma and Serum, ed. P. B. Gahan (Dordrecht: Springer Netherlands), 275-282.
49. Vickers, K. C., Palmisano, B. T., Shoucri, B. M., Shamburek, R. D., and Remaley, A. T. (2011). MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat. Cell Biol. 13, 423-433. doi: 10.1038/ncb2210
50. Villa, C., Ridolfi, E., Fenoglio, C., Ghezzi, L., Vimercati, R., Clerici, F., et al. (2013). Expression of the transcription factor Sp1 and its regulatory hsa-miR-29b in peripheral blood mononuclear cells from patients with Alzheimer's disease. J. Alzheimers Dis. 35, 487-494. doi: 10.3233/JAD-122263
51. West, M. J., Coleman, P. D., Flood, D. G., and Troncoso, J. C. (1994). Differences in the pattern of hippocampal neuronal loss in normal ageing and Alzheimer's disease. Lancet 344, 769-772. doi: 10.1016/S0140-6736(94)92338-8
52. Wolfe, M. S. (2006). The gamma-secretase complex: membrane-embedded proteolytic ensemble. Biochemistry 45, 7931-7939. doi: 10.1021/bi060799c
53. Xu, P., Guo, M., and Hay, B. A. (2004). MicroRNAs and the regulation of cell death. Trends Genet. 20, 617-624. doi: 10.1016/j.tig.2004.09.010
54. Zernecke, A., Bidzhekov, K., Noels, H., Shagdarsuren, E., Gan, L., Denecke, B., et al. (2009). Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection. Sci. Signal. 2, ra81. doi: 10.1126/scisignal.2000610